http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005525991-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7125 |
| filingDate | 2002-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2005525991-A |
| titleOfInvention | Nucleic acid based compounds and methods of use thereof |
| abstract | The present invention provides compounds capable of treating hepatitis infections, particularly hepatitis B virus infection. The present inventors have now found compounds and compositions that are particularly useful for the treatment of viral infections. Preferred compounds of the present invention may have significant activity against hepatitis B virus. The compounds of the present invention are small nucleic acid based molecules, comprising at least two nucleoside units, and typically comprising no more than about 2, 3, 4, 5 or 6 nucleotides, preferably It contains no more than about 2, 3 or 4 nucleotide units, even more preferably it contains 2 or 3 nucleotide units in total. The compounds of the present invention comprise at least one nucleoside unit comprising one or more modifications from a “natural” nucleic acid. Preferred compounds of the present invention include compounds having phosphorothioate internucleotide linkages and / or phosphoramidate internucleotide linkages. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021511305-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014500230-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016164148-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7181938-B2 |
| priorityDate | 2001-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.